Dabigatran Etexilate 46708-0636-06
- Manufacturer
- Alembic Pharmaceuticals Limited
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 14, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA215233
Need to source Dabigatran Etexilate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dabigatran Etexilate Mesylate | 150 mg/1 |
Drug Class
Direct Thrombin Inhibitor [EPC]Thrombin Inhibitors [MoA]
Selected Package
46708-0636-06Selected10 BLISTER PACK in 1 CARTON (46708-636-06) / 6 CAPSULE in 1 BLISTER PACK
Other packages for this product(2)
180 CAPSULE in 1 BOTTLE (46708-636-45)
60 CAPSULE in 1 BOTTLE (46708-636-60)